Overview

Study Evaluating Etanercept in the Treatment of Subjects With Ankylosing Spondylitis

Status:
Completed
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
This study will represent the sponsor's first controlled study of etanercept in Chinese subjects with Ankylosing Spondytitis (AS). This trial is designed to assess the safety and efficacy of etanercept compared to placebo in the treatment of patients with AS.
Phase:
Phase 3
Details
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Treatments:
Etanercept